|
|
|
|
| Advertisement |
 |
|
|
| Top Story |
 |
|
Can Trump Plan Serve as Model for What Ails Europe? |
Now Donald Trump has made his pitch to tackle the challenge of paying for drugs in the US, speculation is rife about what the impact could be around the world—and healthcare payers in Europe are combing through his blueprint to see if any of his ideas might be worth a try locally. Reflector reports
... /Read more/ |
|
|
|
| Calendar |
|
/ June 19–20: Rare Disease Innovation Summit / |
|
Boston, MA |
|
/ June 21–22: Disruptive Downstream Technologies / |
|
San Diego, CA |
|
/ October 15–17: 28th Annual Sharing Conference: Compliance / |
|
National Harbor, MD |
|
/ November 13–14: Due Diligence for Life Sciences M&A, Partnerships and Divestitures / |
|
Philadelphia, PA |
|
/ November 14–15: Commercial Data Insights 2018 / |
|
Philadelphia, PA |
|
/ November 14–15: 5th Annual Global Compliance Congress for Life Sciences / |
|
London, UK |
|
/ November 28–29: Compliant Patient Support Programs Summit / |
|
Chicago, IL |
|
/ December 4–5: Managed Markets Compliance Congress
2018 / |
|
Philadelphia, PA |
|
/ December 5–6: Bio/Pharma Compliance Congress on Non-Promotional Activities / |
|
Philadelphia, PA |
|
|
|
| Industry update |
|
//
Mesoblast Limited (Melbourne, Australia) appointed Josh Muntner as Chief Financial Officer. Josh will be based in New York.
//
Cancer Research UK (Oxford, UK) appointed Tony Hickson as the charity's new chief business officer.
//
Horizon Discovery Group appointed Terry Pizzie as Chief Executive Officer and Board Director.
//
Motif Bio appointed Stephanie Noviello, M.D., MPH as Vice President, Clinical Development.
//
Immuno-oncology company Nouscom (Basel, Switzerland) appointed Adrian Woolfson M.D., Ph.D. as Chief Medical Officer.
//
Recipharm AB (Stockholm, Sweden) announced the appointment of Tobias Hagglov as the company's new Chief Financial Officer, effective later in the year.
|
|
|
|
|
